Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Issues FY 2014 Revenue Guidance In Line With Analysts' Estimates-Conference Call


Wednesday, 14 Aug 2013 05:00pm EDT 

Angiodynamics Inc announced that for fiscal 2014, it expects modest revenue growth of basically 1% to 3%. The Company reported revenue of $342.03 million for fiscal 2013. According to I/B/E/S estimates, analysts were expecting the Company to report revenue of $348.66 million for fiscal 2014. 

Company Quote

19.02
-0.12 -0.63%
19 Dec 2014